Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Retrospective, Observational Clinical Study to Evaluate Clinical Outcome Measures and Safety Profiles for Patients With SDDD Treated With STALIF® C, or M, Ti or FLX Implants for 1 and 2 Levels.

NCT05610397 is registered in ClinicalTrials.gov with Centinel Spine as lead sponsor.

NCT NCT05610397
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05610397 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Retrospective, Observational Clinical Study to Evaluate Clinical Outcome Measures and Safety Profiles for Patients With SDDD Treated With STALIF® C, or M, Ti or FLX Implants for 1 and 2 Levels.
Lead sponsor
Centinel Spine
Phase
Observational
Overall status
Unknown status
Start date
April 24, 2023
Completion date
September 30, 2024
Enrollment
200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

degenerative disc disease, grade 1 spondylolisthesis, retrolisthesis, symptomatic cervical disc disease